No Data
No Data
Mangoceuticals, Inc. Initiates Investigation Into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
Mangoceuticals | 10-Q: Q3 2024 Earnings Report
Mangoceuticals Signs Consulting Deal With CFO Johnston
Mangoceuticals Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
Express News | Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
Update: Mangoceuticals 'Strongly Refutes' Eli Lilly's Claims About Copying Weight-Loss Drugs